The effects of mutational processes and selection on driver mutations across cancer types

The effects of mutational processes and selection on driver mutations across cancer types

Epidemiological evidence has long associated environmental mutagens with increased cancer risk. However, links between specific mutation-causing processes and the acquisition of individual driver mutations have remained obscure. Here we have used public cancer sequencing data from 11,336 cancers of...

Полное описание

Библиографические подробности
Главные авторы:	Temko, D, Tomlinson, I, Severini, S, Schuster-Boeckler, P, Graham, T
Формат:	Journal article
Опубликовано:	Springer Nature 2018

Схожие документы

The effects of mutational processes and selection on driver mutations across cancer types
по: Daniel Temko, и др.
Опубликовано: (2018-05-01)

Author Correction: The effects of mutational processes and selection on driver mutations across cancer types
по: Daniel Temko, и др.
Опубликовано: (2020-04-01)

Mutational landscape of cancer-driver genes across human cancers
по: Musalula Sinkala
Опубликовано: (2023-08-01)

Finding driver mutations in cancer: Elucidating the role of background mutational processes.
по: Anna-Leigh Brown, и др.
Опубликовано: (2019-04-01)

5-hydroxymethylcytosine marks regions with reduced mutation frequency
по: Schuster-Boeckler, P, и др.
Опубликовано: (2016)

An analysis of mutational signatures of synonymous mutations across 15 cancer types
по: Yannan Bin, и др.
Опубликовано: (2019-12-01)

Mutational signature distribution varies with DNA replication timing and strand asymmetry
по: Tomkova, M, и др.
Опубликовано: (2018)

Significant associations between driver gene mutations and DNA methylation alterations across many cancer types.
по: Yun-Ching Chen, и др.
Опубликовано: (2017-11-01)

5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
по: Tomkova, M, и др.
Опубликовано: (2016)

SDH mutations in cancer.
по: Bardella, C, и др.
Опубликовано: (2011)

SDH mutations in cancer
по: Bardella, C, и др.
Опубликовано: (2011)

Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
по: Runjun D. Kumar, и др.
Опубликовано: (2017-07-01)

5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA
по: Marketa Tomkova, и др.
Опубликовано: (2016-05-01)

Mutations, evolutionary theory and cancer.
по: Tomlinson, I
Опубликовано: (1993)

Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog.
по: Tomlinson, I, и др.
Опубликовано: (1999)

Tissue-Predisposition to Cancer Driver Mutations
по: Luriano Peters, и др.
Опубликовано: (2024-01-01)

Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs
по: Ng, AS, и др.
Опубликовано: (2023)

Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
по: Rebecca C Poulos, и др.
Опубликовано: (2018-11-01)

The mutation rate and cancer.
по: Tomlinson, I, и др.
Опубликовано: (1996)

Multiomics analysis of tumor mutational burden across cancer types
по: Lin Li, и др.
Опубликовано: (2021-01-01)

Tug-of-war between driver and passenger mutations in cancer and other adaptive processes
по: McFarland, Christopher D., и др.
Опубликовано: (2015)

Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neo-antigen burden and immune response
по: Temko, D, и др.
Опубликовано: (2018)

How many mutations in a cancer?
по: Tomlinson, I, и др.
Опубликовано: (2002)

Mutation profiling of cancer drivers in Brazilian colorectal cancer
по: Wellington dos Santos, и др.
Опубликовано: (2019-09-01)

Replicative DNA polymerase mutations in cancer.
по: Heitzer, E, и др.
Опубликовано: (2014)

Replicative DNA polymerase mutations in cancer
по: Heitzer, E, и др.
Опубликовано: (2014)

Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
по: Michael B. Mumphrey, и др.
Опубликовано: (2023-08-01)

Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions
по: John K. L. Wong, и др.
Опубликовано: (2022-01-01)

Tissue, cell and stage specificity of (epi)mutations in cancers.
по: Sieber, O, и др.
Опубликовано: (2005)

KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways
по: Koushik Mondal, и др.
Опубликовано: (2024-07-01)

Driver Mutations in Lung Cancer—Mapping the Way Forward
по: Arun Chandrasekharan
Опубликовано: (2022-07-01)

Cis-regulatory mutations with driver hallmarks in major cancers
по: Zhongshan Cheng, и др.
Опубликовано: (2021-03-01)

Advances on Driver Mutations of Small Cell Lung Cancer
по: Bing TONG, и др.
Опубликовано: (2016-04-01)

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer.
по: Jasmine Foo, и др.
Опубликовано: (2015-09-01)

Mutations in Cancer Driver Genes: An Insight into Prostate Cancer Progression
по: Sahdeo, и др.
Опубликовано: (2019-09-01)

Identification of Single Nucleotide Non-coding Driver Mutations in Cancer
по: Kok A. Gan, и др.
Опубликовано: (2018-02-01)

CDMPred: a tool for predicting cancer driver missense mutations with high-quality passenger mutations
по: Lihua Wang, и др.
Опубликовано: (2024-09-01)

Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
по: Ming-Jun Shi, и др.
Опубликовано: (2020-09-01)

Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles.
по: Houriiyah Tegally, и др.
Опубликовано: (2020-01-01)

Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden
по: Jan Budczies, и др.
Опубликовано: (2018-12-01)